Skip to main content
FinSpry Logo
FinSpry
SLNO logo
SLNO
(NASDAQ)
Soleno Therapeutics, Inc.
$39.49-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Soleno Therapeutics (SLNO) Stock Price & Financial Analysis

Soleno Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$36.00 - $40.08
52-Week High$90.32
52-Week Low$29.43
Open$36.25
Volume3.57M
Average Volume (3M)3.57M
Market Cap2.15B
Shares Outstanding54.33M
P/E Ratio (TTM)96.20
Price to Sales (P/S)10.55
Price to Book (P/B)4.46
EV/EBITDA68.43
Revenue (TTM)190.41M
Net Income (TTM)20.89M
Free Cash Flow (TTM)46.73M
EPS (TTM)$0.38
Profit Margin10.97%
Operating Margin7.85%
Return on Equity (ROE)4.64%
Debt to Equity0.01
50-Day MA$38.07
200-Day MA$57.50
52-Week Change-45.81%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Soleno Therapeutics

What is the current stock price for SLNO?

As of the latest trading session, SLNO stock trades at $39.49. The 52-week range is $29.43–$90.32, with a day range of $36.00–$40.08.

What is the P/E ratio for SLNO?

Soleno Therapeutics's trailing P/E ratio is 96.2, meaning investors pay $96.2 for every $1 of annual earnings. Soleno Therapeutics operates in the Healthcare sector.

Does SLNO pay dividends?

Soleno Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SLNO?

Based on 4 analysts, the consensus for SLNO is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SLNO?

Soleno Therapeutics's market capitalization is $2.15B, classifying it as a mid-cap company. Soleno Therapeutics operates in the Healthcare sector within the Biotechnology industry.